TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT07574593: NORM-HF Pivotal Study

Sponsor: Foundry Innovation & Research 1, Limited (FIRE1) · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 800 pts

Competing Trials Overlap

14 Active Trials

Excess Burn Exposure

$6,175,200

Rescue Site Savings

+$4,083,600

Unlock Full NCT07574593 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07574593 Rescue Dossier →